News 2016-08-06
Porton’s Semi Annual Senior Management Working Conference August 6, 2016
Chongqing, China, August 6, 2016: Porton Fine Chemicals, Ltd. held its semi-annual senior management working conference on August 6, 2016. Led by Chairman Oliver Ju and President Andrew Xu, senior executives from the Company’s R&D, Manufacturing Operations, Planning, Business Development and Key Account Management functions and overseas subsidiaries reviewed progress made during the first half of FY 2016 and plans for the second half. Porton continues to make robust advances towards its corporate goals and service mission of helping global pharmaceutical companies more efficiently realize best health outcomes for their patients through chemical process innovation and high-quality production of custom APIs and drug intermediates.
Others
More
News 2025-03-21
Porton's Near-Term Target Validated by the SBTi
March 20, 2025, Chongqing—Porton Pharma Solutions Ltd. (Porton) announced today that its near-term greenhouse gas emissions reductions targets have been formally validated by the Science Based Targets initiative (SBTi). This milestone not only signifies its strategic breakthrough in climate governance, but also demonstrates that its decarbonization roadmap is aligned with the 1.5°C climate mitigation pathway.
News 2025-03-19
Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T Cell Therapy Development
Cranbury, New Jersey, March 19, 2025 — Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing novel T‑cell therapies for both solid tumors and hematologic malignancies.
